chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 48.0
Sex: M
Vaccine: COVID19
Symptoms: Illness, SARS-CoV-2 test, Somnolence, Wheezing
Clinical narrative: Still has diarrhea 2 weeks later; Still has metallic taste in mouth; Breathing bad; Wheezing; Could not walk; Hands numb; Felt really sick; Can't stay awake; This spontaneous case was reported by a consumer and describes the occurrence of DIARRHOEA (Still has diarrhea 2 weeks later), DYSGEUSIA (Still has metallic taste in mouth), DYSPNOEA (Breathing bad), WHEEZING (Wheezing) and GAIT DISTURBANCE (Could not walk) in a 48-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On 31-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 02-Apr-2021, the patient experienced DIARRHOEA (Still has diarrhea 2 weeks later), DYSGEUSIA (Still has metallic taste in mouth), DYSPNOEA (Breathing bad), WHEEZING (Wheezing), GAIT DISTURBANCE (Could not walk), HYPOAESTHESIA (Hands numb), ILLNESS (Felt really sick) and SOMNOLENCE (Can't stay awake). At the time of the report, DIARRHOEA (Still has diarrhea 2 weeks later) and DYSGEUSIA (Still has metallic taste in mouth) had not resolved and DYSPNOEA (Breathing bad), WHEEZING (Wheezing), GAIT DISTURBANCE (Could not walk), HYPOAESTHESIA (Hands numb), ILLNESS (Felt really sick) and SOMNOLENCE (Can't stay awake) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On an unknown date, SARS-CoV-2 test: negative (Negative) Tested 3 times,test were negative each time.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant product information was not provided. Treatment information includes Inhaler.   Most recent FOLLOW-UP information incorporated above includes: On 26-May-2021: Additional information received and patient stated that still not feeling well
Age: 43.0
Sex: M
Vaccine: COVID19
Symptoms: Body temperature, Chills, Feeling abnormal, Lethargy, Pyrexia
Clinical narrative: Felt lethargic; Felt "crappy"; Woke up middle of the night; Have fever of 99.3-100.1 degrees F; Puked; Woke up middle of the night with chills; This spontaneous case was reported by a consumer and describes the occurrence of LETHARGY (Felt lethargic), FEELING ABNORMAL (Felt "crappy"), SLEEP DISORDER (Woke up middle of the night), PYREXIA (Have fever of 99.3-100.1 degrees F) and VOMITING (Puked) in a 43-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 039A21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.   On 14-Apr-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 14-Apr-2021, the patient experienced LETHARGY (Felt lethargic), FEELING ABNORMAL (Felt "crappy"), SLEEP DISORDER (Woke up middle of the night), PYREXIA (Have fever of 99.3-100.1 degrees F), VOMITING (Puked) and CHILLS (Woke up middle of the night with chills). The patient was treated with IBUPROFEN for Fever, at an unspecified dose and frequency and PARACETAMOL (TYLENOL) for Fever, at an unspecified dose and frequency. On 16-Apr-2021, LETHARGY (Felt lethargic), FEELING ABNORMAL (Felt "crappy"), VOMITING (Puked) and CHILLS (Woke up middle of the night with chills) had resolved. At the time of the report, SLEEP DISORDER (Woke up middle of the night) had resolved and PYREXIA (Have fever of 99.3-100.1 degrees F) had not resolved.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 14-Apr-2021, Body temperature: 99.3-100.1 (High) fever of 99.3-100.1 degrees F.         Concomitant product use was not provided by the reporter. Action taken with mRNA-1273 in response to the events was not applicable.
Age: 43.0
Sex: M
Vaccine: COVID19
Symptoms: Sleep disorder, Vomiting
Clinical narrative: Felt lethargic; Felt "crappy"; Woke up middle of the night; Have fever of 99.3-100.1 degrees F; Puked; Woke up middle of the night with chills; This spontaneous case was reported by a consumer and describes the occurrence of LETHARGY (Felt lethargic), FEELING ABNORMAL (Felt "crappy"), SLEEP DISORDER (Woke up middle of the night), PYREXIA (Have fever of 99.3-100.1 degrees F) and VOMITING (Puked) in a 43-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 039A21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.   On 14-Apr-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 14-Apr-2021, the patient experienced LETHARGY (Felt lethargic), FEELING ABNORMAL (Felt "crappy"), SLEEP DISORDER (Woke up middle of the night), PYREXIA (Have fever of 99.3-100.1 degrees F), VOMITING (Puked) and CHILLS (Woke up middle of the night with chills). The patient was treated with IBUPROFEN for Fever, at an unspecified dose and frequency and PARACETAMOL (TYLENOL) for Fever, at an unspecified dose and frequency. On 16-Apr-2021, LETHARGY (Felt lethargic), FEELING ABNORMAL (Felt "crappy"), VOMITING (Puked) and CHILLS (Woke up middle of the night with chills) had resolved. At the time of the report, SLEEP DISORDER (Woke up middle of the night) had resolved and PYREXIA (Have fever of 99.3-100.1 degrees F) had not resolved.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 14-Apr-2021, Body temperature: 99.3-100.1 (High) fever of 99.3-100.1 degrees F.         Concomitant product use was not provided by the reporter. Action taken with mRNA-1273 in response to the events was not applicable.
Age: 57.0
Sex: F
Vaccine: COVID19
Symptoms: Axillary pain, Breast pain, Pain in extremity, Vaccination site pain
Clinical narrative: breast pain; pain in the back of the injection arm; pain in the arm pit; injection arm soreness; This spontaneous case was reported by a consumer (subsequently medically confirmed) and describes the occurrence of BREAST PAIN (breast pain), PAIN IN EXTREMITY (pain in the back of the injection arm), AXILLARY PAIN (pain in the arm pit) and VACCINATION SITE PAIN (injection arm soreness) in a 57-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 044A21A and 031B21A) for COVID-19 vaccination.     The patient's past medical history included No adverse event. Concomitant products included MULTIVITAMINES AND MINERALS for an unknown indication.   On 12-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 09-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 13-Mar-2021, the patient experienced VACCINATION SITE PAIN (injection arm soreness). On 19-Mar-2021, the patient experienced BREAST PAIN (breast pain), PAIN IN EXTREMITY (pain in the back of the injection arm) and AXILLARY PAIN (pain in the arm pit). On 14-Mar-2021, VACCINATION SITE PAIN (injection arm soreness) had resolved. At the time of the report, BREAST PAIN (breast pain), PAIN IN EXTREMITY (pain in the back of the injection arm) and AXILLARY PAIN (pain in the arm pit) had resolved. Not Provided      mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) dosing remained unchanged.       Treatment information was not provided.   This case was linked to MOD21-077255 (E2B Linked Report).; Sender's Comments:  MOD21-077255:
Age: 44.0
Sex: F
Vaccine: COVID19
Symptoms: Underdose
Clinical narrative: 0.4ml second dose; This spontaneous case was reported by a pharmacist and describes the occurrence of UNDERDOSE (0.4ml second dose) in a 44-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 041B21A) for COVID-19 vaccination.     No Medical History information was reported.    On 18-Apr-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) .4 ml. On 19-Apr-2021, the patient experienced UNDERDOSE (0.4ml second dose). On 19-Apr-2021, UNDERDOSE (0.4ml second dose) had resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.
Age: 71.0
Sex: F
Vaccine: COVID19
Symptoms: Pain in extremity
Clinical narrative: sore arm; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (sore arm) in a 71-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 006B21A and 025B21A) for COVID-19 vaccination.     The patient's past medical history included Food allergy (Corn and gluten) and Allergy to antibiotic (azithromycin, penicillin and Sulfonamide).   On 18-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 15-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 18-Mar-2021, the patient experienced PAIN IN EXTREMITY (sore arm). At the time of the report, PAIN IN EXTREMITY (sore arm) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   Concomitant medications: hypothyroidism medication   This case was linked to US-MODERNATX, INC.-MOD-2021-080118, US-MODERNATX, INC.-MOD-2021-080175 (E2B Linked Report).; Sender's Comments:  US-MODERNATX, INC.-MOD-2021-080118:Husband's case crosslinked US-MODERNATX, INC.-MOD-2021-080175:
Sex: F
Vaccine: COVID19
Symptoms: Chills, Pyrexia
Clinical narrative: Fever; Chills; This spontaneous case was reported by a consumer and describes the occurrence of PYREXIA (Fever) and CHILLS (Chills) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 043B21A) for COVID-19 vaccination.     No medical history was reported.    On 17-Apr-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. In April 2021, the patient experienced PYREXIA (Fever) and CHILLS (Chills). At the time of the report, PYREXIA (Fever) and CHILLS (Chills) outcome was unknown. Not Provided          Action taken with mRNA-1273 (Moderna COVID-19 Vaccine) in response to the events was not applicable. No Concomitant  information was  provided. No Treatment information was  provided.      This case was linked to US-MODERNATX, INC.-MOD-2021-080319 (E2B Linked Report).; Sender's Comments:  US-MODERNATX, INC.-MOD-2021-080319:crosslinked
Age: 67.0
Sex: M
Vaccine: COVID19
Symptoms: Cough, Headache, Influenza like illness, Myalgia, Nausea
Clinical narrative: flu like symptoms; pain; cough; headache; nausea; aches; This spontaneous case was reported by a consumer and describes the occurrence of INFLUENZA LIKE ILLNESS (flu like symptoms), PAIN (pain), COUGH (cough), HEADACHE (headache) and NAUSEA (nausea) in a 67-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 027A21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concurrent medical conditions included Sleep apnea (He has sleep apnea.). Concomitant products included ALKA 4-COMPLEX, DIOSMIN (VASCULERA) for Varicose vein.    On 12-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced INFLUENZA LIKE ILLNESS (flu like symptoms), PAIN (pain), COUGH (cough), HEADACHE (headache), NAUSEA (nausea) and MYALGIA (aches). At the time of the report, INFLUENZA LIKE ILLNESS (flu like symptoms), PAIN (pain), COUGH (cough), HEADACHE (headache) and MYALGIA (aches) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown Route) was unknown.
Age: 67.0
Sex: M
Vaccine: COVID19
Symptoms: Pain
Clinical narrative: flu like symptoms; pain; cough; headache; nausea; aches; This spontaneous case was reported by a consumer and describes the occurrence of INFLUENZA LIKE ILLNESS (flu like symptoms), PAIN (pain), COUGH (cough), HEADACHE (headache) and NAUSEA (nausea) in a 67-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 027A21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concurrent medical conditions included Sleep apnea (He has sleep apnea.). Concomitant products included ALKA 4-COMPLEX, DIOSMIN (VASCULERA) for Varicose vein.    On 12-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced INFLUENZA LIKE ILLNESS (flu like symptoms), PAIN (pain), COUGH (cough), HEADACHE (headache), NAUSEA (nausea) and MYALGIA (aches). At the time of the report, INFLUENZA LIKE ILLNESS (flu like symptoms), PAIN (pain), COUGH (cough), HEADACHE (headache) and MYALGIA (aches) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown Route) was unknown.
Age: 62.0
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site bruising, Vaccination site discolouration, Vaccination site pruritus, Vaccination site rash
Clinical narrative: Itchy rash on that started outside the area of the injection; Itchy rash on that started outside the area of the injection, rash on again when taking a shower; The left arm as quart size to half dollar size black to blue mark; The left arm as quart size to half dollar size black to blue mark; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE BRUISING (The left arm as quart size to half dollar size black to blue mark), VACCINATION SITE DISCOLOURATION (The left arm as quart size to half dollar size black to blue mark), VACCINATION SITE PRURITUS (Itchy rash on that started outside the area of the injection) and VACCINATION SITE RASH (Itchy rash on that started outside the area of the injection, rash on again when taking a shower) in a 62-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     The patient's past medical history included Heartburn. Concurrent medical conditions included Migraine, Arthritis, Hypertension (Blood pressure) and Sleep difficult. Concomitant products included CETIRIZINE for Allergy, NAPROXEN for Arthritis, OMEPRAZOLE for Heartburn, MEDROXYPROGESTERONE and ESTRADIOL for Hormone replacement therapy, HYDROCHLOROTHIAZIDE for Hypertension, ALPRAZOLAM for Insomnia, SUMATRIPTAN for Migraine, FLUTICASONE PROPIONATE, PROPANOL, VENLAFAXINE, CYCLOBENZAPRINE, CORTISONE and MARIJUANA for an unknown indication.    On 08-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 09-Apr-2021, the patient experienced VACCINATION SITE BRUISING (The left arm as quart size to half dollar size black to blue mark), VACCINATION SITE DISCOLOURATION (The left arm as quart size to half dollar size black to blue mark) and VACCINATION SITE RASH (Itchy rash on that started outside the area of the injection, rash on again when taking a shower). On 17-Apr-2021, the patient experienced VACCINATION SITE PRURITUS (Itchy rash on that started outside the area of the injection). On 12-Apr-2021, VACCINATION SITE BRUISING (The left arm as quart size to half dollar size black to blue mark) and VACCINATION SITE DISCOLOURATION (The left arm as quart size to half dollar size black to blue mark) had resolved. At the time of the report, VACCINATION SITE PRURITUS (Itchy rash on that started outside the area of the injection) had resolved and VACCINATION SITE RASH (Itchy rash on that started outside the area of the injection, rash on again when taking a shower) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       It was reported that the vaccination site bruise was easily bruised It was reported that the patient is scheduled for cortisone knee injections for both legs on 22-APR-2021 Treatment using cortisone gel over the counter was reported
Sex: F
Vaccine: COVID19
Symptoms: Dizziness, Head discomfort, Muscle twitching, Paraesthesia
Clinical narrative: Pressure in head; Muscle contractions in both arms; Tingling in arms and legs; Light headedness; This spontaneous case was reported by a medical assistant and describes the occurrence of HEAD DISCOMFORT (Pressure in head), MUSCLE TWITCHING (Muscle contractions in both arms), PARAESTHESIA (Tingling in arms and legs) and DIZZINESS (Light headedness) in a 24-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 006B21A) for COVID-19 vaccination.     The patient's past medical history included No adverse event.    On 23-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced HEAD DISCOMFORT (Pressure in head), MUSCLE TWITCHING (Muscle contractions in both arms), PARAESTHESIA (Tingling in arms and legs) and DIZZINESS (Light headedness). At the time of the report, HEAD DISCOMFORT (Pressure in head), MUSCLE TWITCHING (Muscle contractions in both arms), PARAESTHESIA (Tingling in arms and legs) and DIZZINESS (Light headedness) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Patient's doctor ordered  an MRI to look further into symptoms. no concomitant medication provided. No treatment medications were reported.
Sex: M
Vaccine: COVID19
Symptoms: Product temperature excursion issue
Clinical narrative: patient received dose from vial that experience temperature excursion; This spontaneous case was reported by a consumer and describes the occurrence of PRODUCT TEMPERATURE EXCURSION ISSUE (patient received dose from vial that experience temperature excursion) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced PRODUCT TEMPERATURE EXCURSION ISSUE (patient received dose from vial that experience temperature excursion). At the time of the report, PRODUCT TEMPERATURE EXCURSION ISSUE (patient received dose from vial that experience temperature excursion) had resolved. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       no concomitant medication was reported  no treatment medication was reported
Sex: M
Vaccine: COVID19
Symptoms: Device use confusion, Headache, Pain, Temperature intolerance
Clinical narrative: Potential third dose administration; Possible dose administered outside of temperature range; soreness; Headache; This spontaneous case was reported by a consumer (subsequently medically confirmed) and describes the occurrence of PAIN (soreness), HEADACHE (Headache), TEMPERATURE INTOLERANCE (Possible dose administered outside of temperature range) and DEVICE USE CONFUSION (Potential third dose administration) in a 60-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 031721A and 046A21A) for COVID-19 vaccination.     The patient's past medical history included No adverse event.   On 15-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) at an unspecified dose. On 12-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to at an unspecified dose. On 19-Mar-2021, the patient experienced PAIN (soreness) and HEADACHE (Headache). On 12-Apr-2021, the patient experienced TEMPERATURE INTOLERANCE (Possible dose administered outside of temperature range). On 19-Apr-2021, the patient experienced DEVICE USE CONFUSION (Potential third dose administration). At the time of the report, PAIN (soreness) and HEADACHE (Headache) had resolved and TEMPERATURE INTOLERANCE (Possible dose administered outside of temperature range) and DEVICE USE CONFUSION (Potential third dose administration) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) and mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Treatment included Tylenol. Concomitant medications were not provided.   This case was linked to US-MODERNATX, INC.-MOD-2021-080352 (E2B Linked Report).; Reporter's Comments: The consumer is taking Tylenol, as advised by their HCP to try to alleviate the symptoms.; Sender's Comments:  US-MODERNATX, INC.-MOD-2021-080352:1st dose case
Sex: F
Vaccine: COVID19
Symptoms: Induration, Inflammation, Swelling, Vaccination site erythema, Vaccination site swelling
Clinical narrative: Swelling on injection site; Swelling several inches below injection site; Red inflammation; Red inflammation; Swellings were hard; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE SWELLING (Swelling on injection site), SWELLING (Swelling several inches below injection site), VACCINATION SITE ERYTHEMA (Red inflammation), INFLAMMATION (Red inflammation) and INDURATION (Swellings were hard) in a 78-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 021B21A) for COVID-19 vaccination.     The patient's past medical history included No adverse event. Concomitant products included CALCIUM for an unknown indication, CYANOCOBALAMIN, FOLIC ACID (VITAMIN B12 & FOLIC ACID).    On 17-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced VACCINATION SITE SWELLING (Swelling on injection site), SWELLING (Swelling several inches below injection site), VACCINATION SITE ERYTHEMA (Red inflammation), INFLAMMATION (Red inflammation) and INDURATION (Swellings were hard). At the time of the report, VACCINATION SITE SWELLING (Swelling on injection site), SWELLING (Swelling several inches below injection site), VACCINATION SITE ERYTHEMA (Red inflammation) and INFLAMMATION (Red inflammation) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant medications includes:Blood pressure meds Heart meds Meds for restless leg syndrome Osteoporosis meds Antibiotics, there is no treatment povided   Reporter did not allow further contact
Sex: M
Vaccine: COVID19
Symptoms: Headache, Parosmia
Clinical narrative: Smelling constant chemical smell; Headache; This spontaneous case was reported by a consumer and describes the occurrence of PAROSMIA (Smelling constant chemical smell) and HEADACHE (Headache) in a 43-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 12-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 13-Apr-2021, the patient experienced HEADACHE (Headache). On 14-Apr-2021, the patient experienced PAROSMIA (Smelling constant chemical smell). At the time of the report, PAROSMIA (Smelling constant chemical smell) and HEADACHE (Headache) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.
Age: 39.0
Sex: M
Vaccine: COVID19
Symptoms: Product storage error
Clinical narrative: vaccination was not entirely thawed to room temp; This spontaneous case was reported by a physician and describes the occurrence of PRODUCT STORAGE ERROR (vaccination was not entirely thawed to room temp) in a 39-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 029L20A) for COVID-19 vaccination.     The patient's past medical history included No adverse event (No relevant medical history).    On 18-Jan-2021 at 8:00 AM, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 18-Jan-2021 at 8:00 AM, the patient experienced PRODUCT STORAGE ERROR (vaccination was not entirely thawed to room temp). On 18-Jan-2021 at 8:00 AM, PRODUCT STORAGE ERROR (vaccination was not entirely thawed to room temp) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Concomitant product use was not provided/unknown by the reporter. Treatment information was not provided/unknown.
Age: 34.0
Sex: F
Vaccine: COVID19
Symptoms: Headache, Pain in extremity
Clinical narrative: Arm pain; Little headache; This spontaneous case was reported by a patient and describes the occurrence of PAIN IN EXTREMITY (Arm pain) and HEADACHE (Little headache) in a 34-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 027A21A) for COVID-19 vaccination.     No Medical History information was reported.    On 25-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced PAIN IN EXTREMITY (Arm pain) and HEADACHE (Little headache). At the time of the report, PAIN IN EXTREMITY (Arm pain) and HEADACHE (Little headache) outcome was unknown. Not Provided      mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosing remained unchanged.       The patient did not have any pre-existing medical condition.  No concomitant mediations were reported.  Treatment information was not provided.   This case was linked to US-MODERNATX, INC.-MOD-2021-081274 (E2B Linked Report). This case was linked to MOD-2021-081274.   Reporter did not allow further contact; Sender's Comments:  US-MODERNATX, INC.-MOD-2021-081274:
Age: 63.0
Sex: M
Vaccine: COVID19
Symptoms: Feeling abnormal, Illness
Clinical narrative: This spontaneous case reported by a consumer, describes the occurrence of feeling abnormal (felt really bad) and illness (sick) in a 63-year-old male patient who received mRNA-1273 (Moderna COVID-19 vaccine, batch# 038B21A) for COVID-19 immunization. No medical history reported. On Apr 18, 2021, patient received the first dose of mRNA-1273 (Moderna COVID-19 vaccine), unknown route; 1 dosage form. On Apr 18, 2021, patient experienced feeling abnormal (felt really bad) and illness (sick). On Apr 20, 2021, feeling abnormal (felt really bad) and illness (sick) resolved. The action taken with mRNA-1273 (Moderna COVID-19 vaccine), intramuscular: unknown. No concomitant medication or treatment information provided.
Sex: F
Vaccine: COVID19
Symptoms: Myalgia, Rash macular
Clinical narrative: Have two red blotches; Arm is sore; This spontaneous case was reported by a consumer and describes the occurrence of RASH MACULAR (Have two red blotches) and MYALGIA (Arm is sore) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 18-Apr-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced RASH MACULAR (Have two red blotches) and MYALGIA (Arm is sore). At the time of the report, RASH MACULAR (Have two red blotches) and MYALGIA (Arm is sore) outcome was unknown.            No medical history reported. No concomitant drugs reported. No treatment drugs reported.    Reporter did not allow further contact
Age: 31.0
Sex: F
Vaccine: COVID19
Symptoms: Chills, Diarrhoea, Fatigue, Nausea, Pain
Clinical narrative: diarrhea; violent shaking chills/could not stop shaking; felt achy; Fever; chills; nausea; fatigue; This spontaneous case was reported by a consumer and describes the occurrence of DIARRHOEA (diarrhea), TREMOR (violent shaking chills/could not stop shaking), PAIN (felt achy), PYREXIA (Fever) and CHILLS (chills) in a 31-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 038T5214) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On 14-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 14-Apr-2021, the patient experienced DIARRHOEA (diarrhea), TREMOR (violent shaking chills/could not stop shaking), PAIN (felt achy), PYREXIA (Fever), CHILLS (chills), NAUSEA (nausea) and FATIGUE (fatigue). At the time of the report, DIARRHOEA (diarrhea), TREMOR (violent shaking chills/could not stop shaking), PAIN (felt achy), PYREXIA (Fever), CHILLS (chills), NAUSEA (nausea) and FATIGUE (fatigue) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant medication information was not reported. Treatment information as not reported.    Reporter did not allow further contact
Age: 31.0
Sex: F
Vaccine: COVID19
Symptoms: Pyrexia, Tremor
Clinical narrative: diarrhea; violent shaking chills/could not stop shaking; felt achy; Fever; chills; nausea; fatigue; This spontaneous case was reported by a consumer and describes the occurrence of DIARRHOEA (diarrhea), TREMOR (violent shaking chills/could not stop shaking), PAIN (felt achy), PYREXIA (Fever) and CHILLS (chills) in a 31-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 038T5214) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On 14-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 14-Apr-2021, the patient experienced DIARRHOEA (diarrhea), TREMOR (violent shaking chills/could not stop shaking), PAIN (felt achy), PYREXIA (Fever), CHILLS (chills), NAUSEA (nausea) and FATIGUE (fatigue). At the time of the report, DIARRHOEA (diarrhea), TREMOR (violent shaking chills/could not stop shaking), PAIN (felt achy), PYREXIA (Fever), CHILLS (chills), NAUSEA (nausea) and FATIGUE (fatigue) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant medication information was not reported. Treatment information as not reported.    Reporter did not allow further contact
Sex: F
Vaccine: COVID19
Symptoms: Breast swelling
Clinical narrative: Breast Swelling; This spontaneous case was reported by a consumer and describes the occurrence of BREAST SWELLING (Breast Swelling) in a 59-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No reported medical history.  The patient's past medical history included No adverse event.    On 16-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 16-Apr-2021, the patient experienced BREAST SWELLING (Breast Swelling). At the time of the report, BREAST SWELLING (Breast Swelling) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.
Age: 55.0
Sex: M
Vaccine: COVID19
Symptoms: Hypopnoea, Muscle discomfort, Myalgia
Clinical narrative: muscle pain was stated as making them breath shallower; muscle pain was stated as making them breath shallower because it hurt; Strange pain in left pectoral muscle; muscle aches; muscle pain; This spontaneous case was reported by a patient and describes the occurrence of HYPOPNOEA (muscle pain was stated as making them breath shallower), MUSCLE DISCOMFORT (muscle pain was stated as making them breath shallower because it hurt), MYALGIA (Strange pain in left pectoral muscle), MYALGIA (muscle aches) and MYALGIA (muscle pain) in a 55-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 031L20A) for COVID-19 vaccination.     Concurrent medical conditions included Diabetes. Concomitant products included LISINOPRIL and METFORMIN for an unknown indication.   On 19-Apr-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 20-Apr-2021, the patient experienced HYPOPNOEA (muscle pain was stated as making them breath shallower), MUSCLE DISCOMFORT (muscle pain was stated as making them breath shallower because it hurt), MYALGIA (Strange pain in left pectoral muscle), MYALGIA (muscle aches) and MYALGIA (muscle pain). At the time of the report, HYPOPNOEA (muscle pain was stated as making them breath shallower), MUSCLE DISCOMFORT (muscle pain was stated as making them breath shallower because it hurt), MYALGIA (Strange pain in left pectoral muscle), MYALGIA (muscle aches) and MYALGIA (muscle pain) outcome was unknown.            Only medication taken for treatment was a generic Tylenol.
Age: 81.0
Sex: F
Vaccine: COVID19
Symptoms: Pruritus, Scratch, Swelling, Urticaria
Clinical narrative: Hives; Became itchy; Sensation that wants to scratch as if it was an itch; A bump that appears in the skin, some big and some little, and is mainly on her arms; This spontaneous case was reported by a physician and describes the occurrence of URTICARIA (Hives), PRURITUS (Became itchy), SCRATCH (Sensation that wants to scratch as if it was an itch) and SWELLING (A bump that appears in the skin, some big and some little, and is mainly on her arms) in an 82-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 0D1A21A) for COVID-19 vaccination.     No medical history was provided by the reporter.  Concomitant products included VITAMIN E NOS (VITAMIN E [VITAMIN E NOS]), MULTIVITAMIN [VITAMINS NOS] and ASPIRIN [ACETYLSALICYLIC ACID] for an unknown indication.   On 05-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 02-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient experienced URTICARIA (Hives), PRURITUS (Became itchy), SCRATCH (Sensation that wants to scratch as if it was an itch) and SWELLING (A bump that appears in the skin, some big and some little, and is mainly on her arms). At the time of the report, URTICARIA (Hives), PRURITUS (Became itchy), SCRATCH (Sensation that wants to scratch as if it was an itch) and SWELLING (A bump that appears in the skin, some big and some little, and is mainly on her arms) outcome was unknown. Not Provided      For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   Treatment medications were unknown. Action taken with mRNA-1273 in response to the events was not applicable.
Age: 73.0
Sex: F
Vaccine: COVID19
Symptoms: Urinary tract infection
Clinical narrative: urinary tract infection (UTI); This spontaneous case was reported by a consumer (subsequently medically confirmed) and describes the occurrence of URINARY TRACT INFECTION (urinary tract infection (UTI)) in a 73-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 006821A) for COVID-19 vaccination.     No medical history was provided by the reporter.     On 24-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 19-Apr-2021, the patient experienced URINARY TRACT INFECTION (urinary tract infection (UTI)). The patient was treated with NITROFURANTOIN at a dose of 100mg for 7 days. At the time of the report, URINARY TRACT INFECTION (urinary tract infection (UTI)) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No concomitant medications reported
Sex: M
Vaccine: COVID19
Symptoms: Asthenia, Fatigue, Pain in extremity, Somnolence
Clinical narrative: tired; pain on left arm from shoulder to elbow area; no energy; Slept 13-14 hrs; felt weak; This spontaneous case was reported by a consumer and describes the occurrence of FATIGUE (tired), PAIN IN EXTREMITY (pain on left arm from shoulder to elbow area), FATIGUE (no energy) and SOMNOLENCE (Slept 13-14 hrs) in a 40-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     The patient's past medical history included No adverse event (No medical history reported).    On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) at an unspecified dose. On 22-Mar-2021, the patient experienced FATIGUE (tired), PAIN IN EXTREMITY (pain on left arm from shoulder to elbow area), FATIGUE (no energy) and SOMNOLENCE (Slept 13-14 hrs). At the time of the report, FATIGUE (tired), PAIN IN EXTREMITY (pain on left arm from shoulder to elbow area), FATIGUE (no energy) and SOMNOLENCE (Slept 13-14 hrs) outcome was unknown. Not Provided          This case was linked to US-MODERNATX, INC.-MOD-2021-081715 (E2B Linked Report).; Sender's Comments:  US-MODERNATX, INC.-MOD-2021-081715:cross link Dose 2
Sex: F
Vaccine: COVID19
Symptoms: Chills, Pain, Pyrexia
Clinical narrative: fever; chills; body ache; This spontaneous case was reported by a physician and describes the occurrence of PYREXIA (fever), CHILLS (chills) and PAIN (body ache) in a 70-year-old female patient who received mRNA-1273 (batch no. 047A21A) for COVID-19 vaccination.     Concomitant products included LEVOTHYROXINE and ATORVASTATIN for an unknown indication.    On 23-Mar-2021, the patient received first dose of mRNA-1273 (Intramuscular) 1 dosage form. On an unknown date, the patient experienced PYREXIA (fever), CHILLS (chills) and PAIN (body ache). At the time of the report, PYREXIA (fever), CHILLS (chills) and PAIN (body ache) had resolved. Not Provided      The action taken with mRNA-1273 (Intramuscular) was unknown.   For mRNA-1273 (Intramuscular), the reporter did not provide any causality assessments.   At some point her husband tested positive for COVID-19. She didn't take the test and directly decided to stay home.  Now she feels alright and recently tested negative for COVID-19. Treatment included ibuprofen, Nyquil and Dayquil.   This case was linked to MOD21-079084 (E2B Linked Report).; Sender's Comments:  MOD21-079084:cross linked
Age: 72.0
Sex: F
Vaccine: COVID19
Symptoms: Blood blister, Haematoma, Rash, Skin haemorrhage
Clinical narrative: Hematomas on the leg; Blood blisters that run down her legs; Rash all over her body which bleeds; Bad rash all over her body; This spontaneous case was reported by a consumer (subsequently medically confirmed) and describes the occurrence of HAEMATOMA (Hematomas on the leg), BLOOD BLISTER (Blood blisters that run down her legs), SKIN HAEMORRHAGE (Rash all over her body which bleeds) and RASH (Bad rash all over her body) in a 72-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 036A21A and 013M20A) for COVID-19 vaccination.     No Medical History information was reported.   On 12-Mar-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 12-Apr-2021, received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. In March 2021, the patient experienced SKIN HAEMORRHAGE (Rash all over her body which bleeds) and RASH (Bad rash all over her body). On an unknown date, the patient experienced HAEMATOMA (Hematomas on the leg) and BLOOD BLISTER (Blood blisters that run down her legs). At the time of the report, HAEMATOMA (Hematomas on the leg), BLOOD BLISTER (Blood blisters that run down her legs), SKIN HAEMORRHAGE (Rash all over her body which bleeds) and RASH (Bad rash all over her body) had not resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No concomitant products are being used as per the reporter. Treatment for the events included betamethasone cream and a pill she was prescribed by her doctor, that has already run out, and she couldn't remember the name.
Age: 63.0
Sex: M
Vaccine: COVID19
Symptoms: Fatigue, Vaccination site pain
Clinical narrative: fatigue; vaccination site pain; This spontaneous case was reported by a physician and describes the occurrence of VACCINATION SITE PAIN (vaccination site pain) and FATIGUE (fatigue) in a 63-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for an unknown indication.    Co-suspect product included non-company product ADALIMUMAB (HUMIRA) for an unknown indication.    The patient's past medical history included No adverse reaction (no medical History Reported ).   On 28-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient received dose of ADALIMUMAB (HUMIRA) (Subcutaneous) at an unspecified dose. On an unknown date, the patient experienced VACCINATION SITE PAIN (vaccination site pain) and FATIGUE (fatigue). At the time of the report, VACCINATION SITE PAIN (vaccination site pain) and FATIGUE (fatigue) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Reporter did not allow further contact
Age: 17.0
Sex: F
Vaccine: COVID19
Symptoms: Product administered to patient of inappropriate age
Clinical narrative: received 1st dose of Moderna vaccine under 18 Years of age; This spontaneous case was reported by a pharmacist and describes the occurrence of PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE (received 1st dose of Moderna vaccine under 18 Years of age) in a 17-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 044B21A and 033c21a) for COVID-19 vaccination.     No Medical History information was reported.   On 17-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 15-May-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 17-Apr-2021, the patient experienced PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE (received 1st dose of Moderna vaccine under 18 Years of age). On 17-Apr-2021, PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE (received 1st dose of Moderna vaccine under 18 Years of age) had resolved. Not Provided      For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No concomitant medication provided.  No treatment details were provided.   Most recent FOLLOW-UP information incorporated above includes: On 21-May-2021: Non significant follow up received on 21-05-2021, patient ethnicity updated.
Age: 95.0
Sex: F
Vaccine: COVID19
Symptoms: Nausea, Pain, Vaccination site swelling
Clinical narrative: aches, and pains; large red raised area on the shot site; Nausea; This spontaneous case was reported by a consumer and describes the occurrence of NAUSEA (Nausea), PAIN (aches, and pains) and VACCINATION SITE SWELLING (large red raised area on the shot site) in a 95-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 014M20A) for COVID-19 vaccination.     The patient's past medical history included No adverse event.    On 22-Mar-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 20-Apr-2021, the patient experienced NAUSEA (Nausea). On an unknown date, the patient experienced PAIN (aches, and pains) and VACCINATION SITE SWELLING (large red raised area on the shot site). At the time of the report, NAUSEA (Nausea) and VACCINATION SITE SWELLING (large red raised area on the shot site) outcome was unknown. Not Provided          This case was linked to US-MODERNATX, INC.-MOD-2021-082942, US-MODERNATX, INC.-MOD-2021-082892, MOD21-079883 (E2B Linked Report).; Sender's Comments:  US-MODERNATX, INC.-MOD-2021-082942:1st dose US-MODERNATX, INC.-MOD-2021-082892: MOD21-079883:
Age: 85.0
Sex: F
Vaccine: COVID19
Symptoms: Fatigue, Gait inability, Headache, Insomnia, Malaise
Clinical narrative: Fatigue; Tired; Dragging herself; Distress; Going through a difficult time; headache; sleepless night; loud screaming sounds; Having just three and half hours of sleep; Vaccination site pain; tired; nightmares/Frightening dreams; Vaccination site pain; This spontaneous case was reported by an other health professional and describes the occurrence of PAIN IN EXTREMITY (pain in arm), FATIGUE (tired), NIGHTMARE (nightmares/Frightening dreams), HEADACHE (headache) and INSOMNIA (sleepless night) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 040B21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included Skin cancer. Concurrent medical conditions included Blood pressure, Bipolar disorder (she do not have episodes), Depression (she do not have episodes), Allergy and Rotator cuff tear (right shoulder). Concomitant products included TRIAMTERENE for an unknown indication.    On 13-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 13-Apr-2021, the patient experienced PAIN IN EXTREMITY (pain in arm), FATIGUE (tired), NIGHTMARE (nightmares/Frightening dreams) and PAIN IN EXTREMITY (Arm hurts). On 14-Apr-2021, the patient experienced HEADACHE (headache), INSOMNIA (sleepless night), SLEEP TERROR (loud screaming sounds) and INSOMNIA (Having just three and half hours of sleep). On 21-Apr-2021, the patient experienced STRESS (Distress) and MALAISE (Going through a difficult time). On an unknown date, the patient experienced FATIGUE (Fatigue), FATIGUE (Tired) and GAIT INABILITY (Dragging herself). At the time of the report, PAIN IN EXTREMITY (pain in arm), FATIGUE (tired), NIGHTMARE (nightmares/Frightening dreams), HEADACHE (headache), INSOMNIA (sleepless night), SLEEP TERROR (loud screaming sounds), PAIN IN EXTREMITY (Arm hurts), INSOMNIA (Having just three and half hours of sleep), FATIGUE (Fatigue), FATIGUE (Tired), GAIT INABILITY (Dragging herself), STRESS (Distress) and MALAISE (Going through a difficult time) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.